ORT.pptx

srijitghoshal 1,145 views 16 slides Aug 24, 2022
Slide 1
Slide 1 of 16
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16

About This Presentation

Oral Rehydration Therapy


Slide Content

A Case Study on Assigned by - Prof. Dr. Mahesh Gadekar Oral Rehydration Therapy

ORAL REHYDRATION THERAPY Oral rehydration therapy (ORT) is a treatment for dehydration. It involves drinking a special mixture of water, glucose and salts (ORS) to restore the amount of fluids, sugars and electrolytes in the body to normal levels.

Introduction This case lays emphasis on high child mortality rate in developing regions like Africa and south Asia due to diarrhoea, regardless in the presence of easy, low cost treatment which is oral rehydration therapy. ORT treated extreme dehydration caused by diarrhoea which was the leading cause of death among young children.

Mission To reduce child mortality rate due diarrhoea with the help of Oral Rehydration Therapy (ORT).

Case Outline Defining Diarrhoea and child mortality Treatments before ORT Promotion and adoption of ORT Stagnation of ORT Utilization Modifications in ORT Overcoming the challenges to increase ORT Utilization

Treatments Before ORT Before ORT Diarrhoeal Dehydration were typically treated with Intravenous Fluids. It was able to decrease the mortality rate from cholera from over 30% to less than 1% Intravenous Hydration was relatively complex. It required specialized equipments and trained professionals. It was very expensive. It was deemed to be an unfit solution for people from remote & resource-poor environments.

Promotion & Adoption of ORT ORT came into the market as a low-cost, simple to administer substitution of Intravenous Hydration. Multiple clinical studies proved that ORT have similar efficacy to Intravenous Hydration. During 1971 Cholera Epidemic Dr. Mahalanabis demonstrated that ORT could be administered by patients’ family members. In 1978 WHO advised that ORT can be used beyond Cholera. During early 1980s WHO & UNICEF officially recommended use of ORT to treat Diarrhoeal Dehydration. Due to increase in the use of ORT, Diarrhoea related mortality decreased from 4.6 Million in 1980 to 3.3 Million in 1990. BARC promoted ORT to estimated 13 Million households in Bangladesh by the year 1990 and also provided the citizens training to make home-made solutions. During early 1990s UNICEF estimated that over 35% of diarrhoea episodes were treated with ORT.

Stagnation of ORT Utilization After so much promotion and success of ORT, after 10 years Diarrhoea still remained the second largest cause of child mortality. In the late 1990s and early 2000s focus of the global health community shifted towards health emergencies like AIDS and Malaria. ORT also faced issues to get their funding for promotion at that time. Some Developing countries showed inefficiency in procurement and distribution of ORS and Zinc Tablets due to poor coordination among involved organizations.

Issues in the Case Even though ORT is an effective low cost treatment for diarrhoea it’s progress has stalled in the 2000s with 1.5 M deaths per year. Misalignment in demand and supply for ORS Poor logistical execution at country level, ORS was unable to reach the targeted rural population Shifting priorities of organization to different diseases.

SWOT Analysis Strengths Weakness Threats Opportunities Low cost and easily available. Easy to administer. Highly efficacious. Easy to manufacture. Pharmacists do not consider it as a real medicine. Possible failure of 7 point plan. Due to low cost, there is not much monetary gain for producers and suppliers. ORS subsided the symptoms and not cure the the diarrhoea. Lack of financing for in-country zinc production. Insufficient clean water supply in developing countries. Employment opportunities by in-country production. Low penetration of ORT.

5 C’ s for Targeting Market Competitors NGOS Govt. Agencies Patients, Families WHO UNICEF BARC USAID John Hopkin Medical College 1.Technological – To make the product more palatable using same components 2. Economical– Though the product is inexpensive it is able to sustain at low cost in the market Public & Private Organizations Donors Field Partners IV fluid administrators Global Health Emergencies like HIV and Malaria. Customer Collaborators Context Companies

Answer : there are several factors that influence ORT utilization - According to USA IDs project, better product design, packaging and marketing can improve the uptake of ORT. Use of bundled kits instead of separate zinc, ORS tablets. Commercializing the product can improve the distribution systems and encourage pharmacists to prescribe ORS. Charging for the poorest patients can reduce the ORT utilization in rural areas. What influences ORT utilization? In driving utilization. What are the roles of patients, providers and the system? Question 1

Question 2 Answer : There are several loop holes in designing an implementing ORT as treatment for diarrhea - 1. Problems due to improper training : Anecdotal Evidence revealed improper use ORT by the health workers. 2. Problems due to logistics : Poor coordination among involved organizations led to insufficiencies in procurement and distribution of ORS. The most Surprising thing in the case was the misalignment of demand and supply of ORS. ORS packets were collecting dust in health ministry controlled warehouses; while many pharmacy and clinics reported shortage of ORS Are the problems with ORT unexpected? What if anything is surprising about the case?

Question 3 Answer : Dr. Nancy Binkin and colleagues were given 7 point plan for diarrhea control by WHO and UNICEF, which included treatment package and prevention package - Dr Nancy Binkin and colleagues should consider opportunities to strengthen partnerships with national govt. to improve supply chain management They should also use distribution networks of private sector companies to distribute ORS. Innovation in packaging and product design should be improved. The product can be available in various flavors to increase demand/uptake in young children. What should Binkin and her UNICEF/ WHO colleagues do next?

Question 4 Answer : Generalities regarding healthcare system that we can infer from this case - There is lack of awareness among people, regarding this disease and the alarming rate of child mortality. Public health systems are designed poorly as there is not much monitory benefits to either Govt., producers or even suppliers. Demand and supply Gap in healthcare system. Low penetration in most of the areas. Using the ORT situation as an example, what generalities can we draw about large scale global health problems?

THANK YOU
Tags